Literature DB >> 12880778

Isolation of the gene and large-scale expression and purification of recombinant Erythrina cristagalli lectin.

Patrick R Stancombe1, Frances C G Alexander, Roger Ling, Mary A Matheson, Clifford C Shone, John A Chaddock.   

Abstract

Using polymerase chain reaction, the coding sequence for Erythrina cristagalli lectin (ECL) has been cloned and expressed in Escherichia coli. The amplified DNA sequence of ECL is highly homologous to that previously reported for Erythrina corallodendron lectin (ECorL), confirming the absence of introns in the ECL gene. The polypeptide sequences of ECL and ECorL have been compared and five amino acids have been identified that differentiate the two proteins. Recombinant E. cristagalli lectin (recECL) was expressed in E. coli from a genomic clone encoding the mature E. cristagalli lectin gene. Constitutive expression localised recombinant protein in inclusion bodies, which were solubilised, and recECL, subsequently refolded and purified by lactose affinity chromatography. Significant advantages were observed for purification from inclusion bodies rather than from a clone optimised to express soluble protein. A large-scale purification scheme has been developed that can prepare functional recECL from inclusion bodies with a yield of 870 mg/l culture. By the range of characterisation methods employed in this study, it has been demonstrated that recECL is functionally equivalent to native ECL obtained from the E. cristagalli plant. In addition, characterisation of the binding of radiolabelled recECL to cultured dorsal root ganglia demonstrated that recECL binds to a single pool of receptors.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12880778     DOI: 10.1016/s1046-5928(03)00125-6

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  1 in total

1.  Development of hypoallergenic variants of the major horse allergen Equ c 1 for immunotherapy by rational structure based engineering.

Authors:  Jaana Haka; Merja H Niemi; Pekka Mattila; Janne Jänis; Kristiina Takkinen; Juha Rouvinen
Journal:  Sci Rep       Date:  2019-12-27       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.